Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Ipamorelin 5mg Dosage Protocol | PeptideDosages.com

Ipamorelin dosage chart for the 5 mg Vial: typical dose 100 mcg–250 mcg daily, reconstitution to 1.67 mg/mL, and protocol. For research use only.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Ipamorelin (5 mg Vial) Dosage Protocol

Ipamorelin Dosage Chart

Ipamorelin is dosed at 100 mcg–250 mcg daily via subcutaneous injection in educational protocols. A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL. This information is for research and educational use only.

Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.

Typical daily range: 100–250 mcg once daily (gradual titration recommended).

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.

Storage: Lyophilized: 2–8 °C (35.6–46.4 °F) or freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within ~4 weeks.

Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor[1][2]. Its key advantage is high specificity for GH release without triggering ACTH or cortisol elevation, making it one of the safer GH secretagogues with minimal off-target hormonal effects[1][3]. This educational protocol presents a once-daily subcutaneous approach using practical dilution for precise insulin-syringe measurements.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read Ipamorelin Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Standard / Gradual Approach (3.0 mL = ~1.67 mg/mL)

Weeks 1–2

100 mcg

6 units (0.06 mL)

Weeks 3–4

150 mcg

9 units (0.09 mL)

Weeks 5–8

200 mcg

12 units (0.12 mL)

Weeks 9–12

250 mcg

15 units (0.15 mL)

Frequency: Inject once daily subcutaneously, ideally 30–60 minutes before bedtime on an empty stomach to synergize with natural nocturnal GH secretion[4][5]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake vigorously).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

Peptide Vials (Ipamorelin, 5 mg each):

8 weeks ≈ 2 vials

12 weeks ≈ 4 vials

16 weeks ≈ 5 vials

Insulin Syringes (U-100):

Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.

8 weeks (2 vials): 6 mL → 1 × 10 mL bottle

12 weeks (4 vials): 12 mL → 2 × 10 mL bottles

16 weeks (5 vials): 15 mL → 2 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day.

Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100-count boxes

12 weeks: 168 swabs → recommend 2 × 100-count boxes

16 weeks: 224 swabs → recommend 3 × 100-count boxes

Connected topics

Follow this recovery question